CLB vs HPK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLB exhibits a concerning divergence between its current market price ($17.45) and its deterministic value markers, with a Piotroski F-Score of 4/9 indicating only stable health. The stock is trading at a significant premium to both its Graham Number ($9.04) and Intrinsic Value ($4.41), while experiencing a sharp YoY earnings decline of 31.60%. Despite a strong 1-year price rally, the underlying fundamentals—specifically the negative earnings growth and bearish technical trend—suggest the current valuation is unsustainable.
HPK presents as a classic value trap with a Piotroski F-Score of 4/9 (Stable) that masks severe fundamental deterioration. While the current price ($6.34) sits near the Graham Number ($6.1), the growth-based intrinsic value is a dismal $0.91, reflecting a collapse in earnings power. The company is currently paying out 123% of its earnings as dividends, which is fundamentally unsustainable. With revenue declining by 23.3% YoY and a technical trend score of 0/100, the stock is in a clear bearish regime.
Compare Another Pair
Related Comparisons
CLB vs HPK: Head-to-Head Comparison
This page compares Core Laboratories Inc. (CLB) and HighPeak Energy, Inc. (HPK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.